Grants and Contributions:
Title:
Verification on MIGS
Agreement Number:
1019421
Agreement Value:
$75,000.00
Agreement Date:
Jun 3, 2024 - Mar 31, 2025
Description:
Complete prototype validation of innovative MIGS (Minimally Invasive Glaucoma Surgery) devices which will enable bringing glaucoma surgery from the operating room to outpatient clinics. By the end of October 2024, Hexiris will have conducted successful testing of the Functional MIGS on both animal and human cadaveric eyes, demonstrating its efficacy and safety for progression to animal and human clinical trials.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Dieppe, New Brunswick, CA E1A 9T8
Reference Number:
172-2024-2025-Q1-1019421
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
766125470
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.
Amendment Date
Jan 6, 2025
Recipient's Operating Name:
Hexiris
Recipient's Legal Name:
Hexiris Inc.
Federal Riding Name:
Beauséjour
Federal Riding Number:
13002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: